

Understand how Trifluridine stops herpes simplex virus in the eye. Plain-English explanation of how this antiviral eye drop works.
Trifluridine stops herpes simplex virus from replicating by sneaking into the virus's DNA and breaking it from the inside.
If you've been prescribed Trifluridine (Viroptic) for herpes simplex keratitis, you might be curious how a tiny eye drop can fight a virus on the surface of your eye. This guide explains Trifluridine's mechanism of action in plain English — no biochemistry degree required.
Think of the herpes simplex virus as a factory that needs to copy its instruction manual (DNA) to make more copies of itself. Trifluridine works by disguising itself as one of the building blocks the virus needs to write that manual.
Here's the step-by-step:
The key analogy: Trifluridine is a Trojan horse. It looks like something the virus needs, gets pulled inside, and then destroys the virus's ability to reproduce.
Most patients start to see improvement within 2 to 7 days of starting treatment. The corneal ulcer (the damaged area on the surface of the eye) typically begins to heal as the virus stops replicating.
However, full healing takes longer:
If you don't see any improvement after 7 to 14 days, your doctor may reconsider the diagnosis or switch to an alternative treatment. For more on dosing, see our complete guide to Trifluridine uses and dosage.
Not long at all. Trifluridine has an extremely short half-life of about 12 minutes. This means that within an hour, almost all of the medication has been broken down and cleared from your body.
This is why the dosing frequency is so high — every 2 hours during the acute phase. The drug doesn't hang around; it needs to be replenished frequently to maintain a therapeutic concentration on the cornea.
The silver lining of this short half-life is that systemic absorption is negligible. Very little Trifluridine makes it past your eye into the rest of your body, which is why systemic side effects are extremely rare. For more on side effects, see our Trifluridine side effects guide.
Several other antiviral medications are used for herpetic eye infections. Here's how Trifluridine compares:
Ganciclovir 0.15% ophthalmic gel (Zirgan) is a newer option approved for acute herpetic keratitis. It works by a similar mechanism — interfering with viral DNA replication — but it's formulated as a gel that stays on the eye longer. Ganciclovir is dosed 5 times daily during the acute phase (compared to Trifluridine's 9 times), which some patients find more convenient. Both are effective, and the choice often comes down to availability and cost.
Acyclovir is available as an ophthalmic ointment in some countries (though not widely in the US as an eye formulation). It's also used orally to treat herpes simplex infections throughout the body. The mechanism is similar — Acyclovir also mimics a DNA building block — but it requires activation by a viral enzyme (thymidine kinase) to work. Trifluridine does not require this activation step, which gives it an advantage against some resistant strains.
These are older antiviral eye medications that are largely discontinued or rarely used today. They work by similar mechanisms but are less effective and have more side effects than Trifluridine. If your doctor has chosen Trifluridine, you're getting a more modern and well-studied option.
For a full comparison of alternatives, see our article on alternatives to Trifluridine.
Trifluridine works by pretending to be something the herpes simplex virus needs, then sabotaging the virus from within. It's a clever, targeted approach that has been protecting patients' vision for decades. The frequent dosing schedule (every 2 hours) is necessary because the drug clears quickly, but that also means side effects beyond the eye are extremely rare.
If you've been prescribed Trifluridine and need help finding it, search Medfinder to check pharmacy availability near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.